Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

294 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The effect of interferon in the therapy of severe coronavirus infection.
Shajari R, Adeli SH, Bagherzadeh M, Asghari A, Tabaraii R, Alikhani A, Jabbari A, Razavinia F, Shakeri M, Jafari S, Ahmadpour S, Vafaeimanesh J. Shajari R, et al. Among authors: asghari a. J Educ Health Promot. 2023 Apr 28;12:129. doi: 10.4103/jehp.jehp_332_21. eCollection 2023. J Educ Health Promot. 2023. PMID: 37397116 Free PMC article.
Effects of Iranian Polyherbal Syrup (Zufa syrup) on oxygen saturation and clinical symptoms in suspected patients with COVID-19: a triple-blinded, randomized, placebo-controlled trial.
Borujerdi R, Adeli SH, Mohammadbeigi A, Aliasl F, Asghari A, Hormati A, Dehnavi HM, Hoseini F, Asghari M. Borujerdi R, et al. Among authors: asghari m, asghari a. Med Gas Res. 2022 Apr-Jun;12(2):44-50. doi: 10.4103/2045-9912.325991. Med Gas Res. 2022. PMID: 34677151 Free PMC article. Clinical Trial.
Discharge of Confirmed COVID-19 Patients Based on WHO or Regional Criteria? A Cohort Study.
Adeli SH, Parham M, Asghari A, Bagherzade M, Shajari R, Tabarraii R, Shakeri M, Jabbari A, Jafari S, Ahmadpour S, Habibi MA, Khodadai J, Shafiee H, Eskandari N, Dameshghi DO, Masoumi M, Ghomi SYF, Ebrazeh A, Vafaeimanesh J. Adeli SH, et al. Among authors: asghari a. Infect Disord Drug Targets. 2023;23(1):e150822207493. doi: 10.2174/1871526522666220815151958. Infect Disord Drug Targets. 2023. PMID: 36748230
Safety and efficacy of Favipiravir in moderate to severe SARS-CoV-2 pneumonia.
Solaymani-Dodaran M, Ghanei M, Bagheri M, Qazvini A, Vahedi E, Hassan Saadat S, Amin Setarehdan S, Ansarifar A, Biganeh H, Mohazzab A, Khalili D, Hosein Ghazale A, Reza Heidari M, Taheri A, Khoramdad M, Mahdi Asadi M, Nazemieh M, Varshochi M, Abbasian S, Bakhtiari A, Mosaed R, Hosseini-Shokouh SJ, Shahrokhi M, Yassin Z, Ali Zohal M, Qaraati M, Rastgoo N, Sami R, Javad Eslami M, Asghari A, Namazi M, Ziaie S, Jafari-Moghaddam R, Kalantari S, Memarian M, Khodadadi J, Hossein Afshari M, Momen-Heravi M, Behzadseresht N, Reza Mobayen A, Mozafari A, Movasaghi F, Haddadzadeh Shoushtari M, Moazen J. Solaymani-Dodaran M, et al. Among authors: asghari a. Int Immunopharmacol. 2021 Jun;95:107522. doi: 10.1016/j.intimp.2021.107522. Epub 2021 Mar 11. Int Immunopharmacol. 2021. PMID: 33735712 Free PMC article. Clinical Trial.
Molecular epidemiology and multilocus genotyping of Giardia duodenalis in individuals attending major public hospitals in Shiraz, southwestern Iran: A public health concern.
Asghari A, Mahdavi F, Karimi K, Mohammadi MR, Shamsi L, Asgari Q, Motazedian MH, Shahabi S, Sadrebazzaz A. Asghari A, et al. Parasite Epidemiol Control. 2024 Apr 29;25:e00354. doi: 10.1016/j.parepi.2024.e00354. eCollection 2024 May. Parasite Epidemiol Control. 2024. PMID: 38711926 Free PMC article.
294 results